Clinical trial
High Loading ROsuvastatin Pretreatment in Patients Undergoing Elective PCI to Reduce the Incidence of MyocArdial Periprocedural Necrosis : Comparison With Atorvastatin High Dose Reloading.
NCT01228227 is registered in ClinicalTrials.gov with Gennaro Sardella as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High Loading ROsuvastatin Pretreatment in Patients Undergoing Elective PCI to Reduce the Incidence of MyocArdial Periprocedural Necrosis : Comparison With Atorvastatin High Dose Reloading.
- Lead sponsor
- Gennaro Sardella
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- August 31, 2011
- Enrollment
- 310 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
assess the periprocedural myocardial necrosis